Detalhe da pesquisa
1.
Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Nature
; 606(7915): 791-796, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322234
2.
LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.
Proc Natl Acad Sci U S A
; 115(18): E4179-E4188, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29581250
3.
LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
JCI Insight
; 8(15)2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37440313
4.
Rlip76 transports sunitinib and sorafenib and mediates drug resistance in kidney cancer.
Int J Cancer
; 126(6): 1327-38, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19626587
5.
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
Neoplasia
; 22(6): 253-262, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32403054
6.
Functional reconstitution of RLIP76 catalyzing ATP-dependent transport of glutathione-conjugates.
Int J Oncol
; 34(1): 191-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19082490
7.
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.
Oncogene
; 38(28): 5658-5669, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30996246
8.
Diminished drug transport and augmented radiation sensitivity caused by loss of RLIP76.
FEBS Lett
; 582(23-24): 3408-14, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18789326
9.
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor.
Oncotarget
; 7(26): 40690-40703, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276681
10.
P300 regulates the human RLIP76 promoter activity and gene expression.
Biochem Pharmacol
; 85(8): 1203-11, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419874
11.
Role of SMC1 in overcoming drug resistance in triple negative breast cancer.
PLoS One
; 8(5): e64338, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23717600